Farwell Wildon 4
4 · Dyne Therapeutics, Inc. · Filed Nov 16, 2023
Insider Transaction Report
Form 4
Farwell Wildon
Chief Medical Officer
Transactions
- Award
Common Stock
2023-11-15+82,512→ 171,762 total - Award
Stock Option (right to buy)
2023-11-15+32,131→ 32,131 totalExercise: $10.88Exp: 2033-11-14→ Common Stock (32,131 underlying)
Footnotes (3)
- [F1]Consists of shares of Common Stock issuable under 82,512 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on February 15, 2024.
- [F2]Includes 149,311 unvested RSUs.
- [F3]This option was granted on November 15, 2023. The shares underlying the option are scheduled to vest over four years in equal monthly installments through November 15, 2027.